Wantaifu Biotechnology and Bigfish grandly held a strategic cooperation signing ceremony

On August 23, 2023, Zhejiang Wantaifu Biotechnology Co., Ltd. and Hangzhou Bigfish Biotechnology Co., Ltd. held a strategic cooperation signing ceremony.

After the signing ceremony, the two parties had a detailed discussion about the future direction of the IVD industry, taking into account the current economic situation and industry dynamics. Both parties expressed the hope that this cooperation can lead to mutual progress in terms of product technology and marketing, and contribute to a win-win situation. The focus is on achieving high-level and high-quality cooperation to ensure success in a globally integrated economy.

Zhejiang Wantaifu Biotechnology Co., Ltd. was founded in May 2022 with the goal of improving the quality of life and health by developing and providing precise medical solutions. The company specializes in in-vitro diagnostics and focuses on early tumor screening, self-test for infectious diseases, as well as research and development, production, marketing, and servicing of rapid diagnostic reagents and supporting instruments for chronic disease management. The products are exported to over 50 countries and regions worldwide, and are widely used in clinical testing, family health management, chronic disease management, primary medical care, and other areas. Wantaifu Biotechnology boasts a team of Ph.D. technical experts and partners who provide comprehensive solutions.

Hangzhou Bigfish Biotechnology Co., Ltd. is a national high-tech enterprise founded in 2017 that specializes in molecular diagnostic products. The company's goal is to become a leader in genetic testing technology throughout the entire life cycle. With almost 20 years of experience in molecular diagnosis-related instrument software and hardware development, reagent research and development, and instrument reagent manufacturing, the company has become a core player in the industry. The company's instrument reagent supports the industry's first application of the Internet of Things module, an intelligent instrument reagent data management platform, which provides customers with complete automation, intelligence, and industrialization solutions. The company's tenet is to research cutting-edge products and achieve classic brands. It adheres to a rigorous and realistic work style, actively innovates, provides customers with reliable biotechnology services, and aims to become a world-class company in the fields of life sciences and medical health.